Nirvana Life Sciences Inc.
NIRV
CNSX
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.30K | 1.90K | 400.00 | 400.00 | 2.00K |
| Total Receivables | 12.10K | 12.10K | 13.70K | 13.60K | 13.70K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 13.30K | 14.10K | 14.10K | 14.00K | 15.70K |
|
|
|||||
| Total Current Assets | 13.30K | 14.10K | 14.10K | 14.00K | 15.70K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 126.40K | -- |
| Total Assets | 13.30K | 14.10K | 14.10K | 140.50K | 15.70K |
|
|
|||||
| Total Accounts Payable | 143.00K | 184.20K | 81.60K | 109.80K | 134.60K |
| Total Accrued Expenses | 176.00K | 830.60K | 769.40K | 742.00K | 714.50K |
| Short-term Debt | 75.70K | 71.30K | 67.20K | 49.60K | 24.30K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | 5.00K | -- | 5.00K | 5.00K |
| Total Other Current Liabilities | -- | 5.00K | -- | 5.00K | 5.00K |
| Total Current Liabilities | 394.60K | 1.09M | 918.20K | 906.30K | 878.30K |
|
|
|||||
| Total Current Liabilities | 394.60K | 1.09M | 918.20K | 906.30K | 878.30K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 75.70K | 71.30K | 67.20K | 49.60K | 24.30K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00 | -- | 18.20K | 125.00K | 1.50K |
| Total Liabilities | 394.60K | 1.09M | 936.40K | 1.03M | 879.80K |
|
|
|||||
| Common Stock & APIC | 5.70M | 5.01M | 4.78M | 4.97M | 5.01M |
| Retained Earnings | -6.49M | -6.50M | -6.09M | -6.27M | -6.28M |
| Treasury Stock & Other | 415.20K | 415.90K | 386.60K | 411.60K | 405.10K |
| Total Common Equity | -377.70K | -1.07M | -918.20K | -886.90K | -860.50K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -377.70K | -1.07M | -918.20K | -886.90K | -860.50K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -3.60K | -3.60K | -4.00K | -3.90K | -3.70K |
| Total Equity | -381.30K | -1.08M | -922.30K | -890.80K | -864.20K |
|
|
|||||